FOSUN HEALTH Logo

Cervical Cancer Causes

catalogue

Cervical Cancer Causes

Cervical Cancer Causes

Cervical cancer has a cause known with unusual precision: a human papillomavirus infection that the body failed to clear. Everything else — smoking, HIV, contraception, age at first exposure — acts by changing the odds that an infection persists, not by causing cancer directly.

HPV: the necessary cause

Human papillomavirus is a group of more than 200 viruses, of which about a dozen — the high-risk types — infect the genital tract and can drive cells toward cancer. WHO's position is stated plainly: persistent infection with a high-risk HPV type causes nearly all cervical cancer. It is one of very few human cancers for which a single infectious cause has been identified, verified, and turned into a vaccine.

HPV spreads through skin-to-skin sexual contact, not through bodily fluids, which is why condoms reduce but do not eliminate transmission. It is so common that most sexually active people acquire it at some point — and most clear it within a year or two without ever knowing they had it. The infection itself is not a disease; the risk lives in the minority of infections that the immune system fails to clear.

Types 16 and 18

The high-risk types are not interchangeable. HPV 16 and HPV 18 together account for roughly 70% of cervical cancers, with type 16 the stronger driver and the commonest in squamous cancers; type 18 is disproportionately found in adenocarcinoma. A further half-dozen types — 31, 33, 45, 52, 58 among them — account for most of the remainder.

This hierarchy is why vaccination works as it does: every HPV vaccine covers 16 and 18, and the nine-valent vaccine covers the additional five types as well. A woman infected with one type is not protected against the others, which is why vaccination matters before exposure, and why a positive test for one type still leaves the others to screen for.

Infection versus persistent infection

The distinction that matters most in this disease is between an infection — acquired, common, usually cleared — and a persistent infection — the same virus still detectable twelve or twenty-four months later. Cancer is caused by the second, not the first. The viral genes that persist suppress the normal maturation of cervical cells, and the changes they produce accumulate over years: first CIN, then, in a minority, invasive cancer.

This timeline — often a decade or more from infection to cancer — is the reason screening works, and it reframes a positive HPV test. It is not a cancer diagnosis; it is information that this particular infection has not yet cleared and deserves follow-up at a defined interval to see whether it clears or produces a lesion worth treating.

What changes the odds

Whether an HPV infection persists is where the other risk factors act — none of them causes cervical cancer without HPV, but each raises the likelihood that the infection stays and progresses:

  • Smoking — roughly doubles the likelihood that an HPV infection persists, through direct effects on the cervical epithelium and local immunity. It is the strongest behavioural cofactor.
  • Immunosuppression — untreated HIV multiplies risk several-fold, and women on immunosuppressive treatment after transplant need more frequent screening. The immune system is what clears HPV.
  • Long-term oral contraceptive use — reported as a modest cofactor that recedes after stopping, and weighed against contraceptive benefits in practice.
  • Long screening intervals — the cofactor you control most directly: precancer that would be caught and treated at screening instead progresses silently.

Age at first sexual activity and number of partners raise the exposure to HPV — the chance of ever being infected — rather than the biology of persistence. They matter at the population level for vaccination and screening design, and they matter not at all for judging any individual case.

What does not cause it

Cervical cancer collects more myths than most cancers, because its cause is sexually transmitted and the myths are old. The facts:

  • It is not hereditary. Unlike breast or ovarian cancer, it is not driven by inherited genes; a family history does not change the pathway, which runs through HPV and screening.
  • Hygiene does not prevent it. Washing before or after sex does not reach the cells the virus infects; vaccination and screening do.
  • It is not a matter of sexual morality. Any sexually transmitted HPV carries the risk; exposure is near-universal and says nothing about the person.
  • Intrauterine devices do not cause it — IUD use is, if anything, associated with a lower risk in cohort studies.
  • A diagnosis cannot reconstruct a timeline. Infections acquired years earlier can persist or reactivate; the cancer does not say when the virus arrived.

These clarifications are not social decoration — they change behaviour. Women who believe cervical cancer is hereditary skip screening because no one in the family had it; women who believe hygiene protects them skip screening because they feel clean. The screening interval, not the myth, is what decides whether precancer is caught.

Who should think about this

Anyone with a cervix who has ever been sexually active, from the first years of activity onward — the disease's peak burden falls on women in their forties and fifties, but it appears in younger women too, and precancer appears earlier still. Priorities in order:

  • Anyone not vaccinated, or vaccinated after exposure began — screening carries the protection
  • Anyone whose last screening has lapsed past the interval — the highest-yield group for every statistic this disease produces
  • Women with HIV or on immunosuppressive treatment, who need shorter screening intervals
  • Smokers, who can change the one cofactor most within their control
  • Women with a previous high-grade CIN or treated precancer, who need follow-up rather than routine intervals

The unifying point: because the cause is known and the precancer is visible, risk in this disease is modified by actions more than by inheritance. The prevention page sets out the two — vaccination and screening — and how they fit together.

Frequently Asked Questions

If HPV is so common, why do only some women get cervical cancer?

Because infection and persistence are different events. Most HPV infections are cleared by the immune system within one to two years and leave nothing behind. Cancer develops only where a high-risk infection persists for years, and where cofactors — smoking, immunosuppression, missed screening — let the cellular changes it drives accumulate without being caught. Screening interrupts exactly that window, which is why its interval matters more than any single risk factor.

My partner and I are monogamous — do I still need screening?

Yes. Monogamy now does not say what happened before, and HPV can persist silently for years after it was acquired — in either partner, with no symptoms for anyone. The virus, not the relationship, is what screening follows, and the recommendation is unchanged: screening at the standard interval for anyone with a cervix who has ever been sexually active.

Can men carry HPV and pass it on?

Yes, and that is precisely why vaccination now includes boys in many countries. Men carry and transmit HPV without any test or symptom to show it, and the same high-risk types cause cancers in men — of the anus, penis and throat — as well as contributing to the pool of infection that keeps the virus circulating. Vaccinating boys lowers transmission for everyone and protects them directly.

Does the HPV vaccine work if I am already sexually active?

Partially, and it is still worthwhile. The vaccine prevents infection with the types it covers; it does not treat an infection already established. Someone sexually active has likely not acquired every covered type, so the vaccine still protects against the rest — and it protects through the years and partners that follow. That is why guidelines recommend it well into adulthood in many countries, alongside continued screening.

Questions about HPV, vaccination timing, or why your screening interval is what it is?

Our gynaecological team will answer in writing within 48 hours — and if your last screen has lapsed, we will tell you what to arrange first.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*